June 11: The anti-cholesterol drug fenofibrate appears to reduce risks of amputation for patients with diabetes by as much as 36%, a study has found.

The study was published in a special edition on diabetes by The Lancet.

In the study, researchers in Australia ran a five-year trialMore »